Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FQzWunWOxUFIlaEeEF-zZd1J4KwI.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version v2.10.0, adding two more study numbers and indicating that the study now has 14 locations, while the previous version v2.9.7 has been removed.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check17 days agoChange DetectedDifference0.1%
- Check21 days agoChange DetectedThe website was last updated on July 3, 2024, with the previous estimated update date removed.SummaryDifference0.2%
- Check24 days agoChange DetectedThe value 2024-05 has recently changed to 2024-07-02, indicating an update in the information related to the study of pembrolizumab in pediatric participants with various types of cancer, including melanoma, solid tumors, and lymphomas.SummaryDifference9%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.